Table 4.
COVID-19-attributable mortality and resolution of COVID-19.
| 2020 (N = 39) | 2021 (N = 35) | 2022 (N = 106) | Total (N = 180) | |
|---|---|---|---|---|
| Non-COVID-19 related mortality, N (%) | 2 (5.1) | 2 (5.7) | 7 (6.6) | 11 (6.1) |
| COVID-19 related mortality, N (%) | 17 (43.6) | 8 (22.9) | 8 (7.5) | 33 (18.3) |
| Median time between COVID-19 until death, days (min-max) | 37 (7–151) | 37 (7–158) | 57 (3–283) | 39 (3–283) |
| Median follow-up time from SARS-CoV-2 diagnosis, days (min-max) | 96 (7–425) | 60 (7–332) | 158 (3–343) | 119 (3–425) |
| Virologic (PCR) resolution of SARS-CoV-2 in surviving patients, N (%) | 14 (70.0) | 15 (60.0) | 47 (51.6) | 76 (55.9) |
| Median duration virologic SARS-CoV-2 infection, days (min-max) | 24 (6–94) | 54 (13–332) | 51 (5–221) | 50 (5–332) |
| Clinical resolution COVID-19 in surviving patients, N (%) | 6 (30.0) | 9 (36.0) | 38 (41.8) | 53 (39.0) |
| Median duration clinical COVID-19, days (min-max) | 31 (7–157) | 13 (4-82) | 22 (5–218) | 21 (4–218) |
| Missing data COVID-19 resolution, N (%) | 0 (0.0) | 1 (2.9) | 6 (5.7) | 7 (3.9) |